interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Cannabidiol

Generic competition · all medicines · read 12 November 2026

Is there a generic of Cannabidiol, and who makes it?

Cannabidiol appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Cannabidiol1 dosage-form group in the Orange Book
0generic makers listed
  1. Cannabidiol appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Epidiolex. No generic is listed as marketed.

201520202025203020352040204501brand 2018data datePatent 9956186 listed to expire 17 June 2035Patent 10092525 listed to expire 17 June 2035Patent 9956183 listed to expire 17 June 2035Patent 9949937 listed to expire 17 June 2035Patent 10111840 listed to expire 17 June 2035Patent 10137095 listed to expire 17 June 2035Patent 11633369 listed to expire 17 June 2035Patent 10603288 listed to expire 17 June 2035Patent 11357741 listed to expire 17 June 2035Patent 10709671 listed to expire 17 June 2035Patent 10709674 listed to expire 17 June 2035Patent 9956184 listed to expire 17 June 2035Patent 11963937 listed to expire 17 June 2035Patent 9956185 listed to expire 17 June 2035Patent 12064399 listed to expire 17 June 2035Patent 11766411 listed to expire 17 June 2035Patent 11154516 listed to expire 17 June 2035Patent 10849860 listed to expire 17 June 2035Patent 11311498 listed to expire 17 June 2035Patent 10966939 listed to expire 17 June 2035Patent 11446258 listed to expire 17 June 2035Patent 11701330 listed to expire 17 June 2035Patent 10709673 listed to expire 17 June 2035Patent 11065209 listed to expire 13 October 2035Patent 10918608 listed to expire 13 October 2035Patent 11400055 listed to expire 13 October 2035Patent 11096905 listed to expire 13 October 2035Patent 11207292 listed to expire 26 April 2039Patent 11865102 listed to expire 26 April 2039Patent 12102619 listed to expire 1 March 2041Patent 11160795 listed to expire 1 March 2041Patent 11406623 listed to expire 1 March 2041Patent 12661365 listed to expire 24 September 2042Exclusivity ODE-326 to 31 July 2027Exclusivity ODE-332 to 31 July 2027
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 31 July 2027Exclusivity ODE-326 Epidiolex
  • 31 July 2027Exclusivity ODE-332 Epidiolex
  • 17 June 2035Patent 9956186
  • 17 June 2035Patent 10092525
  • 17 June 2035Patent 9956183
  • 17 June 2035Patent 9949937
  • 17 June 2035Patent 10111840
  • 17 June 2035Patent 10137095
  • 17 June 2035Patent 11633369 drug product
  • 17 June 2035Patent 10603288

25 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.